Contemporary role of radiation therapy in the adjuvant or salvage setting following radical prostatectomy

Current Opinion in Urology

Volumn 21, Issue 3, 2011, Pages 206-210

  Cozzarini, Cesare ^a   Di Muzio, Nadia ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

adjuvant; prostatectomy; radiotherapy; salvage; toxicity

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER RELAPSE; CANCER SURVIVAL; HORMONAL THERAPY; HUMAN; PELVIS RADIOGRAPHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; SALVAGE THERAPY;

COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MALE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79955053748     PISSN: 09630643     EISSN: 14736586     Source Type: Journal    
DOI: 10.1097/MOU.0b013e3283449e06     Document Type: Article

References (23)

1. Thompson IM, Tangen CM, Paradelo J, et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial. J Urol 2009; 181:956-962.
2. Ghia AJ, Shrieve DC, Tward JD. Adjuvant radiotherapy use and patterns of care analysis for margin-positive prostate adenocarcinoma with extracapsular extension: postprostatectomy adjuvant radiotherapy - a SEER analysis. Urology 2010; 76:1169-1174.
3. Hoffman KE, Nguyen PL, Chen MH, et al. Recommendations for postprostatectomy radiation therapy in the United States before and after the presentation of randomized trials. J Urol 2011; 185:116-120.
4. Parker C, Catton C, Sydes MR. Early salvage radiotherapy after radical prostatectomy. J Clin Oncol 2010; 28:e45.
5. Briganti A, Karnes JR, Da Pozzo LF, et al. Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy. Eur Urol 2009; 55:261-270.
6. Boorjian SA, Karnes RJ, Crispen PL, et al. Radiation therapy after radical prostatectomy: impact on metastasis and survival. J Urol 2009; 182:2708-2714.
7. Trock BJ, Han M, Freedland SJ, et al. Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy. JAMA 2008; 299:2760-2769. (Pubitemid 351846851)
8. Song C, Kim YS, Hong JH, et al. Treatment failure and clinical progression after salvage therapy inmenwith biochemical recurrence after radical prostatectomy: radiotherapy vs androgen deprivation. BJU Int 2010; 106:188-193.
9. Swanson GP, Hussey MA, Tangen CM, et al. Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794. J Clin Oncol 2007; 25:2225-2229. (Pubitemid 46954647)
10. Cozzarini C, Montorsi F, Fiorino C, et al. Need for high radiation dose (>70 Gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients. Int J Radiat Oncol Biol Phys 2009; 75:966-974.
11. King CR, Kapp DS. Radiotherapy after prostatectomy: is the evidence for dose escalation out there? Int J Radiat Oncol Biol Phys 2008; 71:346-350.
12. Ost P, Fonteyne V, Villeirs G, et al. Adjuvant high-dose intensity-modulated radiotherapy after radical prostatectomy for prostate cancer: clinical results in patients. Eur Urol 2009; 56:669-675
13. Bernard JRJ, Buskirk SJ, Heckman MG, et al. Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: dose-response analysis. Int J Radiat Oncol Biol Phys 2010; 76:735-740.
14. Ost P, De Troyer B, Fonteyne V, et al. A matched control analysis of adjuvant and salvage high-dose postoperative intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys (in press).
15. Choo R, Danjoux C, Gardner S, et al. Prospective study evaluating postoperative radiotherapy plus 2-year androgen suppression for postradical prostatectomy patients with pathologic T3 disease and/or positive surgical margins. Int J Radiat Oncol Biol Phys 2009; 75:407-412.
16. Choo R, Danjoux C, Gardner S, et al. Efficacy of salvage radiotherapy plus 2-year androgen suppression for postradical prostatectomy patients with PSA relapse. Int J Radiat Oncol Biol Phys 2009; 75:983-989.
17. Krauss D, Kestin L, Ye H, et al. Lack of benefit for the addition of androgen deprivation therapy to dose-escalated radiotherapy in the treatment of intermediate- and high-risk prostate cancer. Int J Radiat Oncol Biol Phys 2010 (in press).
18. Goldner G, Dimopoulos J, Potter R. Is the Roach formula predictive for biochemical outcome in prostate cancer patients with minimal residual disease undergoing local radiotherapy after radical prostatectomy? Radiother Oncol 2010; 94:324-327.
19. Ross RW, Zietman AL, Xie W, et al. Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy. Clin Imaging 2009; 33:301-305.
20. Spiotto MT, Hancock SL, King CR. Radiotherapy after prostatectomy: improved biochemical relapse-free survival with whole pelvic compared with prostate bed only for high-risk patients. Int J Radiat Oncol Biol Phys 2007; 69:54-61. (Pubitemid 47247505)
21. Peterson JL, Buskirk SJ, Heckman MG, et al. Late toxicity after postprostatectomy salvage radiation therapy. Radiother Oncol 2009; 93:203-206.
22. Alongi F, Fiorino C, Cozzarini C, et al. IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with postoperative adjuvant or salvage radiotherapy after radical prostatectomy. Radiother Oncol 2009; 93:207-212.
23. Cozzarini C, Fiorino C, Da Pozzo LF, et al. Clinical factors predicting late severe urinary toxicity after postoperative radiotherapy for prostate carcinoma: a single institute analysis of 742 patients. Int J Radiat Oncol Biol Phys (in press).